FDA Flags Recall of Popular Blood Pressure Pills Over Cross-Contamination Concerns

Thousands of Americans taking popular blood pressure medication should examine their medicine cabinets. A routinely prescribed prescription was recalled by the FDA after regular testing found drug traces.

Ziac blood pressure tablets were recalled by the FDA due to cross-contamination. Glenmark Pharmaceuticals’ New Jersey-made medication is taken daily by many hypertensives. Government estimates the recall at 11,000 bottles.

Bisoprolol fumarate and hydrochlorothiazide in Ziac pills have low quantities of ezetimibe, a cholesterol medicine. Health experts believe contamination is low and the recall has had no negative impact.

It affects Ziac 2.5 and 6.25 mg tablets. Bottle counts were 30, 100, and 500. A recall notification contains multiple lot numbers with late 2025 to mid-2026 expiration dates. This was an FDA Class III recall, its lowest. No major health risks should arise.

Even with that comfort, officials advise patients to be cautious and take the recall seriously. Do not stop taking medication if you fear it is from an impacted batch. They should consult a doctor or pharmacist before changing their medication. Sudden blood pressure medication disruptions can be more dangerous than contamination.

Prescription drug recalls are rare but feasible when manufacturing lines make many drugs. Authorities said these flaws were detected early during quality tests before products reach the public.

Healthcare providers and pharmacies countrywide have been notified to help patients identify their bottles during the recall. Most people should check their prescription label or bottle cap lot number and see a doctor.

Frequent Ziac users should follow their doctors’ instructions. This recall has not yet created health issues, but being proactive assures safety and treatment continuation.